Pfizer agrees to buy Global Blood Therapeutics in deal valued at $5.4 billion: WSJ
admin Pfizer Inc. PFE, -1.18% has reached an agreement to buy Global Blood Therapeutics Inc. in…
Read MorePfizer Inc. PFE, -1.18% has reached an agreement to buy Global Blood Therapeutics Inc. in…
Read More
Get ready for more merger mania in pharma sector the rest of the year
Pfizer Inc.’s PFE, +0.45% $5.4 billion acquisition of Global Blood Therapeutics Inc. GBT, -0.02% is…
Read More